drugset
drugset / Trial / NCT05274880

Study to Evaluate the Food Effect on Pharmacokinetics Profile and Safety of CKD-393

NCT05274880 ↗

Phase 1 Completed 28 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

Study to evaluate the food effect on pharmacokinetic profiles and safety of CKD-393 in healthy volunteers

Timeline

Start
2022-06-21
Primary completion
2022-07-15
Completion
2022-07-26

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-393 Unknown — Oral

Indications

type 2 diabetes mellitus